Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal

N Wurtz, B Fall, A Pascual, S Diawara, K Sow, E Baret… - Malaria journal, 2012 - Springer
Background As a result of the widespread resistance to chloroquine and sulphadoxine-
pyrimethamine, artemisinin-based combination therapy (ACT)(including artemether …

Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz …

LMQ Alareqi, MAK Mahdy, YL Lau, MY Fong… - Acta tropica, 2016 - Elsevier
Abstract Since 2005, artesunate (AS) plus sulfadoxine/pyrimethamine (SP) combination has
been adopted as the first-line treatment for uncomplicated malaria in Yemen in response to …

Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern …

P Mula, A Fernández-Martínez, A de Lucio, JM Ramos… - Malaria Journal, 2011 - Springer
Abstract Background In Ethiopia, malaria is caused by Plasmodium falciparum and
Plasmodium vivax, and anti-malarial drug resistance is the most pressing problem …

Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study

B Fall, A Pascual, FD Sarr, N Wurtz, V Richard, E Baret… - Malaria Journal, 2013 - Springer
Abstract Background In 2006, the Senegalese National Malaria Control Programme
recommended artemisinin-based combination therapy (ACT) as the first-line treatment for …

Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata …

P Berzosa, A Esteban-Cantos, L García, V González… - Malaria Journal, 2017 - Springer
Background The emergence of drug resistance in Plasmodium falciparum has been a major
contributor to the global burden of malaria. Drug resistance complicates treatment, and it is …

Antimalarial drug resistance in the Central and Adamawa regions of Cameroon: Prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes

AGB Tuedom, EM Sarah-Matio, CEE Moukoko… - PLoS …, 2021 - journals.plos.org
The spread of Plasmodium falciparum resistant parasites remains one of the major
challenges for malaria control and elimination in Sub Saharan Africa. Monitoring of …

Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.

O Ojurongbe, SI Oyedeji, WA Oyibo… - Wiener Klinische …, 2010 - search.ebscohost.com
Drug resistance against P. falciparum has been recognized as the crucial obstacle to
curbing mortality and morbidity from malaria. We therefore determined the baseline …

Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia

T Eshetu, N Berens-Riha, S Fekadu, Z Tadesse… - Malaria Journal, 2010 - Springer
Background The emergence of drug resistance is a major problem in malaria control.
Combination of molecular genotyping and characterization of mutations or single nucleotide …

Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan

NK Ghanchi, J Ursing, MA Beg, MI Veiga, S Jafri… - Malaria journal, 2011 - Springer
Background Scarce data are available on Plasmodium falciparum anti-malarial drug
resistance in Pakistan. The aim of this study was, therefore, to determine the prevalence of …

Molecular markers in Plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010) …

A Amor, C Toro, A Fernández-Martínez, M Baquero… - Malaria journal, 2012 - Springer
Background Drug resistance is a major problem to control Plasmodium falciparum infection
in endemic countries. During last decade, African countries have changed first-line treatment …